Abstract:Circulating tumor cells (CTCs) have attracted pretty much attention from scientists because of their important relationship with the process of metastasis. Here, we developed a size-based microfluidic chip containing triangular pillar array and filter channel array for detecting single CTCs and CTC clusters independent of tumor-specific markers. The cell populations in chip were characterized by immune-fluorescent staining combining an epithelial marker and a mesenchymal marker. We largely decreased the whole … Show more
“…To demonstrate the suitability of our method for real clinical samples, we replaced the Sgc8c aptamer and the TD05 aptamer with the Lc-17 aptamer and the AP-1 aptamer to target two CTCs with abnormal expression of vimentin and with abnormal expression of cytokeratin (CK) respectively in lung cancer patients. 38,[74][75][76] Aer CTCs were captured by our platform, Cu 2+ and Mg 2+ were added to release CTCs successively. The released CTCs by Cu 2+ or Mg 2+ and unreleased CTCs were collected separately for immunouorescence staining.…”
Section: Ctc Isolation From Cancer Patients' Blood Samplesmentioning
“…To demonstrate the suitability of our method for real clinical samples, we replaced the Sgc8c aptamer and the TD05 aptamer with the Lc-17 aptamer and the AP-1 aptamer to target two CTCs with abnormal expression of vimentin and with abnormal expression of cytokeratin (CK) respectively in lung cancer patients. 38,[74][75][76] Aer CTCs were captured by our platform, Cu 2+ and Mg 2+ were added to release CTCs successively. The released CTCs by Cu 2+ or Mg 2+ and unreleased CTCs were collected separately for immunouorescence staining.…”
Section: Ctc Isolation From Cancer Patients' Blood Samplesmentioning
“…A number of microfluidics‐based technologies have been developed for CTC isolation and biomimicking of tumor microenvironment to evaluate cancer metastasis. Although the capture efficiency can reach 98% with purity of 89% [87] and throughput can reach 3 mL/min [75] for CTC isolation using microfluidic technologies, the performance of these methods is not good enough and still needs further improvement. To better meet the clinical requirements of CTC detection, the technology should tend to the following demands: (a) higher isolation efficiency which may need new technologies or combination of several technologies; (b) specificity verification strategies to prove that the isolated targeted cells are real CTCs which have clinical significance; (c) accuracy and repeatability that apply automated apparatus as much as possible without much intervention from human operators; (d) operability and generalizability; (e) fully heterogeneity consideration to distinguish different CTC subpopulations; and (f) clinical demonstration to prove this technology is useful in clinical trials.…”
Section: Conclusion and Future Perspectivesmentioning
Microfluidic applications on circulating tumor cell isolation and biomimicking of cancer metastasisThe prognosis of malignant tumors is challenged by insufficient means to effectively detect tumors at early stage. Liquid biopsy using circulating tumor cells (CTCs) as biomarkers demonstrates a promising solution to tackle the challenge, because CTCs play a critical role in cancer metastatic process via intravasation, circulation, extravasation, and formation of secondary tumor. However, the effectiveness of the solution is compromised by rarity, heterogeneity, and vulnerability associated with CTCs. Among a plethora of novel approaches for CTC isolation and enrichment, microfluidics leads to isolation and detection of CTCs in a cost-effective and operation-friendly way. Development of microfluidics also makes it feasible to model the cancer metastasis in vitro using a microfluidic system to mimick the in vivo microenvironment, thereby enabling analysis and monitor of tumor metastasis. This paper aims to review the latest advances for exploring the dual-roles microfluidics has played in early cancer diagnosis via CTC isolation and investigating the role of CTCs in cancer metastasis; the merits and drawbacks for dominating microfluidics-based CTC isolation methods are discussed; biomimicking cancer metastasis using microfluidics are presented with example applications on modelling of tumor microenvironment, tumor cell dissemination, tumor migration, and tumor angiogenesis. The future perspectives and challenges are discussed.
“…Recently Gao et al modified an earlier reported size based CTC isolation technology (Huang et al, 2014), which not only improved the device performance but also helped in sequential capture of CTM and CTC separately (Gao et al, 2016). The earlier version of device made use of a series of alternating and parallel microchannels; main channel and side channel, connected to each other through an array of filter channels at regular intervals.…”
Section: Microfluidic Chip With Triangular Pillar Array and Filter Chmentioning
confidence: 99%
“…(i) Bulk filtration (and CTM separation) through two successive sub-regions of triangular micropost array with variable narrowing channel widths (ii) CTC separation through a series of alternating and parallel microchannels (Gao et al, 2016) interconnected through an array of filtered channels (Sarioglu et al, 2015) CTM traverse capillary sized vessels by reversibly reorganizing in to singlefile chain-like geometries (Au et al, 2016)…”
Section: Microfluidic Chip With Tandem Triangular Pillar and Filter Cmentioning
Circulating tumor cells (CTCs) and their clusters, also known as circulating tumor microemboli (CTM), have emerged as valuable tool that can provide mechanistic insights into the tumor heterogeneity, clonal evolution, and stochastic events within the metastatic cascade. However, recent investigations have hinted that CTM may not be mere aggregates of tumor cells but cells comprising CTM exhibit distinct phenotypic and molecular characteristics in comparison to single CTCs. Moreover, in many cases CTM demonstrated higher metastatic potential and resistance to apoptosis as compared to their single cell counterparts. Thus, their evaluation and enumeration may provide a new dimension to our understanding of cancer biology and metastatic cancer spread as well as offer novel theranostic biomarkers. Most of the existing technologies for isolation of hematogenous tumor cells largely favor single CTCs, hence there is a need to devise new approaches, or re-configure the existing ones, for specific and efficient CTM isolation. Here we review existing knowledge and insights on CTM biology. Furthermore, a critical commentary on current and emerging trends in CTM enrichment and characterization along with recently developed ex-vivo CTC expansion methodologies is presented with the aim to facilitate researchers to identify further avenues of research and development.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.